Literature DB >> 11316143

Psychological distress is linked to gastrointestinal symptoms in diabetes mellitus.

S J Talley1, P Bytzer, J Hammer, L Young, M Jones, M Horowitz.   

Abstract

OBJECTIVE: Gastrointestinal (GI) symptoms are common in patients with long-standing diabetes mellitus, but the pathogenesis is controversial. We aimed to determine if GI symptoms are linked to psychological distress in diabetes.
METHODS: A consecutive sample of outpatients with diabetes mellitus (n = 209) and a random sample of community diabetics (n = 892) completed a validated questionnaire measuring GI symptoms, the Hospital Anxiety and Depression (HAD) Scale for anxiety and depression, and the Eysenck short neuroticism scale.
RESULTS: Overall, 42% reported one or more GI symptoms: bloating, abdominal pain, loose stools, and urgency were most common. The mean HAD and neuroticism scores were significantly higher for most GI symptoms (11 of 14, all p < 0.05), and a dose-response relationship was observed. GI symptoms were, in general, approximately twice as frequent in cases with anxiety or depression (HAD > or = 11). Anxiety, depression, and neuroticism were each independently associated with the number of GI symptoms, adjusting for age, gender, duration and type of diabetes, and self-reported glycemic control.
CONCLUSIONS: Increased levels of state anxiety and depression and neuroticism are associated with upper and lower GI symptoms in diabetes mellitus. It is uncertain whether psychological distress is causally linked to symptoms, or whether GI symptoms per se increase levels of anxiety and depression.

Entities:  

Mesh:

Year:  2001        PMID: 11316143     DOI: 10.1111/j.1572-0241.2001.03605.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  20 in total

1.  Metoclopramide in the treatment of diabetic gastroparesis.

Authors:  Allen Lee; Braden Kuo
Journal:  Expert Rev Endocrinol Metab       Date:  2010

Review 2.  Human pancreatic exocrine response to nutrients in health and disease.

Authors:  J Keller; P Layer
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

Review 3.  Pathophysiology and management of diabetic gastropathy: a guide for endocrinologists.

Authors:  Paul Kuo; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 4.  Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting.

Authors:  H P Parkman; M Camilleri; G Farrugia; R W McCallum; A E Bharucha; E A Mayer; J F Tack; R Spiller; M Horowitz; A I Vinik; J J Galligan; P J Pasricha; B Kuo; L A Szarka; L Marciani; K Jones; C R Parrish; P Sandroni; T Abell; T Ordog; W Hasler; K L Koch; K Sanders; N J Norton; F Hamilton
Journal:  Neurogastroenterol Motil       Date:  2009-12-09       Impact factor: 3.598

5.  Association between psychological distress and gastrointestinal symptoms in diabetes mellitus.

Authors:  Abdulbari Bener; Suhaila Ghuloum; Abdulla Oaa Al-Hamaq; Elnour E Dafeeah
Journal:  World J Diabetes       Date:  2012-06-15

Review 6.  Diabetes and the Esophagus.

Authors:  Roberto Monreal-Robles; José M Remes-Troche
Journal:  Curr Treat Options Gastroenterol       Date:  2017-12

Review 7.  Gastrointestinal disturbances in diabetes.

Authors:  Manju Chandran; Neelima V Chu; Steven V Edelman
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

Review 8.  Assessment of the cardiovascular and gastrointestinal autonomic complications of diabetes.

Authors:  Christina Brock; Birgitte Brock; Anne Grave Pedersen; Asbjørn Mohr Drewes; Niels Jessen; Adam D Farmer
Journal:  World J Diabetes       Date:  2016-08-25

9.  Increased prevalence of symptoms of gastroesophageal reflux diseases in type 2 diabetics with neuropathy.

Authors:  Xiangbing Wang; C S Pitchumoni; Khushbu Chandrarana; Neha Shah
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

Review 10.  Diabetic gastroparesis: diagnosis and management.

Authors:  Jing Ma; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.